Levofloxacin selects fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus less frequently than ciprofloxacin

被引:29
作者
Evans, ME [1 ]
Titlow, WB [1 ]
机构
[1] Univ Kentucky, Sch Med, Dept Internal Med, Div Infect Dis, Lexington, KY 40536 USA
关键词
D O I
10.1093/jac/41.2.285
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Seventeen methicillin-resistant Staphylococcus aureus (MRSA) with unique genotypes were examined to determine if resistance occurs more frequently with ciprofloxacin or levofloxacin. The mean single-step resistance rate to 4 x MIC of ciprofloxacin was 1.05 x 10(-5) (range < 4.82 x 10(-11) to 5.06 x 10(-5)), and that to levofloxacin was 4.03 x 10(-6) (range < 3.57 x 10(-13) to 4.10 x 10(-5)) (P < 0.05). When serially passaged, the mean MICs of ciprofloxacin and levofloxacin increased 3.0 +/- 1.5-fold and 1.8 +/- l.4-fold, respectively (P < 0.05). Only four strains became resistant to levofloxacin, but eight became resistant to ciprofloxacin.
引用
收藏
页码:285 / 288
页数:4
相关论文
共 9 条
[1]   CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :319-326
[2]   INCREASING RESISTANCE OF STAPHYLOCOCCUS-AUREUS TO CIPROFLOXACIN [J].
DAUM, TE ;
SCHABERG, DR ;
TERPENNING, MS ;
SOTTILE, WS ;
KAUFFMAN, CA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1862-1863
[3]   ACTIVITY OF NEW QUINOLONES AGAINST CIPROFLOXACIN-RESISTANT STAPHYLOCOCCI [J].
FORSTALL, GJ ;
KNAPP, CC ;
WASHINGTON, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) :1679-1681
[4]   EFFICACY OF OFLOXACIN IN EXPERIMENTAL STAPHYLOCOCCUS-AUREUS ENDOCARDITIS [J].
KAATZ, GW ;
SEO, SM ;
BARRIERE, SL ;
ALBRECHT, LM ;
RYBAK, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) :257-260
[5]   PHARMACODYNAMICS OF LEVOFLOXACIN, OFLOXACIN, AND CIPROFLOXACIN, ALONE AND IN COMBINATION WITH RIFAMPIN, AGAINST METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN AN IN-VITRO INFECTION MODEL [J].
KANG, SL ;
RYBAK, MJ ;
MCGRATH, BJ ;
KAATZ, GW ;
SEO, SM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) :2702-2709
[6]  
MULLIGAN ME, 1987, AM J MED, V82, P215
[7]  
National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS
[8]   EMERGENCE OF CIPROFLOXACIN RESISTANCE IN NOSOCOMIAL METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ISOLATES - RESISTANCE DURING CIPROFLOXACIN PLUS RIFAMPIN THERAPY FOR METHICILLIN-RESISTANT S-AUREUS COLONIZATION [J].
PETERSON, LR ;
QUICK, JN ;
JENSEN, B ;
HOMANN, S ;
JOHNSON, S ;
TENQUIST, J ;
SHANHOLTZER, C ;
PETZEL, RA ;
SINN, L ;
GERDING, DN .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (10) :2151-2155
[9]   EPIDEMIOLOGIC TYPING AND DELINEATION OF GENETIC RELATEDNESS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS BY MACRORESTRICTION ANALYSIS OF GENOMIC DNA BY USING PULSED-FIELD GEL-ELECTROPHORESIS [J].
STRUELENS, MJ ;
DEPLANO, A ;
GODARD, C ;
MAES, N ;
SERRUYS, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (10) :2599-2605